NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Pre-approval Single-patient Expanded Access for Abrocitinib (PF-04965842)

AvailableN/A

Sponsor: Pfizer

Conditions: Severe Uncontrolled Atopic Dermatitis

Interventions: abrocitinib

Provide pre-approval single patient Expanded Access (compassionate use) of abrocitinib for patients with severe uncontrolled atopic dermatitis

Eligibility overview

Sex: ALL

Age: 12 Years to —

Study type: EXPANDED_ACCESS

Eligibility criteria

Must have severe uncontrolled atopic dermatitis refractory to other available treatments